The broad, long-term goal of this project is to advance our understanding of the functional origin of optical signals used in breast tissue characterization and imaging. This will be accomplished using Broadband Diffuse Optical Spectroscopy (DOS), a non-invasive technique that combines multi-frequency frequency-domain photon migration (FDPM) with time-independent near-infrared (NIR) spectroscopy to quantitatively measure bulk tissue absorption and scattering spectra. Our approach has two major components: 1) advancing a hand-held DOS reflectance probe for clinical measurements and 2) combining DOS with MRI and exogenous molecular contrast agents for pre-clinical animal model studies. Each technology development activity is accompanied by basic science and translational research. Translational studies are designed to test the feasibility of optical methods in evaluating breast disease risk, distinguishing between malignant and benign lesions, and characterizing the impact of therapies (e.g. hormone replacement therapy (HRT) and neoadjuvant chemotherapy). Broadband DOS instruments will be placed in 3 clinical performance sites: 1) the Avon Breast Center in the Chao Family Comprehensive Cancer Center at UC Irvine, 2) the Carol Franc Buck Breast Center in the UC San Francisco Comprehensive Cancer Center, and 2) the UCI Beckman Laser Institute Medical Clinic (BLIMC). A translational research infrastructure will be developed in these sites that includes defining procedures for correlating DOS with conventional radiology methods, epidemiologic models and histopathology. Clinical studies will be completed in order to derive predictive """"""""tissue optical indices"""""""" (TOI) for diagnosing disease, monitoring therapies, and understanding risk. Project 1 emphasizes determining how NIR spectral features are affected by alterations in breast physiology and biochemical composition. Our results will provide critical information for Projects 2 and 3 on the optimal utilization of wavelengths and modulation frequencies for breast tissue functional imaging. Extensive utilization of Instrumentation, Software/Computation, and Molecular Probes Cores will take place throughout the proposed research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
1U54CA105480-01
Application #
6824729
Study Section
Special Emphasis Panel (ZCA1)
Project Start
2003-09-29
Project End
2008-08-31
Budget Start
Budget End
Support Year
1
Fiscal Year
2003
Total Cost
Indirect Cost
Name
University of California Irvine
Department
Type
DUNS #
161202122
City
Irvine
State
CA
Country
United States
Zip Code
92697
Ban, H Y; Schweiger, M; Kavuri, V C et al. (2016) Heterodyne frequency-domain multispectral diffuse optical tomography of breast cancer in the parallel-plane transmission geometry. Med Phys 43:4383
Busch, David R; Choe, Regine; Durduran, Turgut et al. (2014) Blood flow reduction in breast tissue due to mammographic compression. Acad Radiol 21:151-61
Wang, Fusheng; Vergara-Niedermayr, Cristobal; Liu, Peiya (2014) Metadata based management and sharing of distributed biomedical data. Int J Metadata Semant Ontol 9:42-57
Busch, David R; Choe, Regine; Rosen, Mark A et al. (2013) Optical malignancy parameters for monitoring progression of breast cancer neoadjuvant chemotherapy. Biomed Opt Express 4:105-21
O'Sullivan, Thomas D; Leproux, Anaïs; Chen, Jeon-Hor et al. (2013) Optical imaging correlates with magnetic resonance imaging breast density and reveals composition changes during neoadjuvant chemotherapy. Breast Cancer Res 15:R14
Roblyer, Darren; O'Sullivan, Thomas D; Warren, Robert V et al. (2013) Feasibility of Direct Digital Sampling for Diffuse Optical Frequency Domain Spectroscopy in Tissue. Meas Sci Technol 24:045501
Leproux, Anaïs; Durkin, Amanda; Compton, Montana et al. (2013) Assessing tumor contrast in radiographically dense breast tissue using Diffuse Optical Spectroscopic Imaging (DOSI). Breast Cancer Res 15:R89
Tichauer, Kenneth M; Samkoe, Kimberley S; Sexton, Kristian J et al. (2012) In vivo quantification of tumor receptor binding potential with dual-reporter molecular imaging. Mol Imaging Biol 14:584-92
Samkoe, Kimberley S; Sexton, Kristian; Tichauer, Kenneth M et al. (2012) High vascular delivery of EGF, but low receptor binding rate is observed in AsPC-1 tumors as compared to normal pancreas. Mol Imaging Biol 14:472-9
O'Sullivan, Thomas D; Cerussi, Albert E; Cuccia, David J et al. (2012) Diffuse optical imaging using spatially and temporally modulated light. J Biomed Opt 17:071311

Showing the most recent 10 out of 74 publications